New therapeutic principle for Parkinsonian dyskinesia shows clinical effect
- Details
- Category: Research
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease. Now, however, researchers at Karolinska Institutet and Lund University in Sweden seem to be close to a novel therapy to this distressing side effect.
Short-term use of hormone replacement therapy associated with increased ovarian cancer risk
- Details
- Category: Research
Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet.
Bacteria protect intestinal tumor model from being killed by immune cells
- Details
- Category: Research
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February 18th in the journal Immunity reveals that the oral pathogen Fusobacterium nucleatum protects a variety of tumor cells from being killed by immune cells.
A new screening method may be able to identify toxic drugs earlier in development
- Details
- Category: Research
A good drug is hard to design: to garner FDA approval and reach consumers, it must not only effectively treat a medical condition, but it must also do so without having side effects that outweigh its benefits. Sometimes, toxic side effects aren't discovered until fairly late in the drug development process, when substantial amounts of time and money have already been invested in clinical trials.
High-cost blood cancer drugs deliver high value
- Details
- Category: Research
Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide reasonable value for money spent. Researchers present this viewpoint, based upon a comprehensive analysis of published cost-effectiveness ratios, online in Blood, the Journal of the American Society of Hematology (ASH).
Another reason to drink wine: It could help you burn fat
- Details
- Category: Research
Drinking red grape juice or wine - in moderation - could improve the health of overweight people by helping them burn fat better, according to a new study coauthored by an Oregon State University researcher. The findings suggest that consuming dark-colored grapes, whether eating them or drinking juice or wine, might help people better manage obesity and related metabolic disorders such as fatty liver.
Compound found in grapes, red wine may help prevent memory loss
- Details
- Category: Research
A compound found in common foods such as red grapes and peanuts may help prevent age-related decline in memory, according to new research published by a faculty member in the Texas A&M Health Science Center College of Medicine. Ashok K. Shetty, Ph.D., a professor in the Department of Molecular and Cellular Medicine and Director of Neurosciences at the Institute for Regenerative Medicine, has been studying the potential benefit of resveratrol, an antioxidant that is found in the skin of red grapes, as well as in red wine, peanuts and some berries.
More Pharma News ...
- Add nature, art and religion to life's best anti-inflammatories
- Does getting an 'expensive' drug affect how much patient benefits?
- Study shows Tamiflu gets patients back on their feet faster, reduces flu complications
- Drug combo suppresses growth of late-stage prostate cancer tumors
- New 'systems genetics' study identifies possible target for epilepsy treatment
- Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors
- Drinking moderate amounts of alcohol is linked to reduced risk of heart failure